Sale by August Troendle of 65653 shares of Medpace Holdings
| MEDP Stock | USD 334.75 2.52 0.76% |
Slightly above 52% of Medpace Holdings' investor base is interested to short. The analysis of overall sentiment of trading Medpace Holdings stock suggests that many investors are impartial at this time. Medpace Holdings' investing sentiment overview a quick insight into current market opportunities from investing in Medpace Holdings. Many technical investors use Medpace Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Medpace |
Filed transaction by Medpace Holdings Inc director. General open market or private sale of non-derivative or derivative security
Read at macroaxis.com
Medpace Holdings Fundamental Analysis
We analyze Medpace Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medpace Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medpace Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
Medpace Holdings is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Medpace Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medpace Holdings stock to make a market-neutral strategy. Peer analysis of Medpace Holdings could also be used in its relative valuation, which is a method of valuing Medpace Holdings by comparing valuation metrics with similar companies.
Peers
Medpace Holdings Related Equities
| ICLR | ICON PLC | 1.39 | ||||
| CRL | Charles River | 0.64 | ||||
| RVTY | Revvity | 0.27 | ||||
| LH | Laboratory | 0.21 | ||||
| IDXX | IDEXX Laboratories | 0.17 | ||||
| QGEN | Qiagen NV | 0.02 | ||||
| MTD | Mettler Toledo | 0.24 | ||||
| IQV | IQVIA Holdings | 0.71 | ||||
| WAT | Waters | 0.73 | ||||
| NEOG | Neogen | 1.54 | ||||
| TWST | Twist Bioscience | 2.50 |
Additional Tools for Medpace Stock Analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.